CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-25 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −12,000 | 104,116 | ||
| 2020-02-25 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −2,000 | 102,116 | ||
| 2020-02-25 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −6,495 | 95,621 | ||
| 2020-02-25 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −12,116 | 83,505 | ||
| 2020-02-25 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −10,834 | 72,671 | ||
| 2020-02-17 | Ferrari Mauro Director | Grant or award | +26,571 | 40,971 | ||
| 2020-01-21 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +33,351 | $5.19 | $173K | 424,536 |
| 2020-01-21 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −6,397 | $47.07 | $301K | 418,139 |
| 2020-01-21 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −6,432 | $47.93 | $308K | 411,707 |
| 2020-01-21 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −10,554 | $49.07 | $518K | 401,153 |
| 2020-01-21 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −2,800 | $49.98 | $140K | 398,353 |
| 2020-01-21 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −10,680 | $51.11 | $546K | 387,673 |
| 2020-01-21 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −3,450 | $52.13 | $180K | 384,223 |
| 2020-01-21 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −33,351 | 116,116 | ||
| 2020-01-13 | De Backer Marianne Director | Purchase | +500 | $54.95 | $27K | 13,000 |
| 2020-01-06 | GIVEN BRUCE D Chief Operating Officer | Sale | −11,847 | $59.57 | $706K | 882,759 |
| 2020-01-06 | GIVEN BRUCE D Chief Operating Officer | Sale | −22,466 | $60.37 | $1.4M | 860,293 |
| 2020-01-06 | GIVEN BRUCE D Chief Operating Officer | Sale | −1,300 | $60.99 | $79K | 858,993 |
| 2020-01-06 | O'Brien Patrick General Counsel | Sale | −5,594 | $59.61 | $333K | 267,406 |
| 2020-01-06 | O'Brien Patrick General Counsel | Sale | −8,931 | $60.43 | $540K | 258,475 |
Page 26 of 38 · 752 trades